Blog

SOUTH SAN FRANCISCO, Calif., March 11, 2026 — CERo Therapeutics Holdings, Inc. (OTCQB: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanism, provides an update through the letter to stockholders and stakeholders from CEO Chris Ehrlich:

To our stockholders and stakeholders:

Following our recent Form 8-K filing confirming receipt of convertible debt funding to support current operations, we believe it is an appropriate time to provide an update on CERo Therapeutics’ operational and scientific progress. Over the past six months, the Company has advanced its clinical development activities, engaged in strategic discussions, and continued to manage resources with fiscal discipline.

During this period, we have progressed the development of our lead candidate, CER-1236, including observations consistent with an acceptable safety and tolerability profile to date, across multiple treated patients. We have also observed biologic activity consistent with the mechanism of the therapy, including approximately 20–70-fold cell expansion, peaking between days 7–14 and followed by continued persistence as measured in peripheral blood. These early observations contribute to our understanding of CER-1236 and support continued clinical evaluation of the program.

Notably, in the second patient treated in our ongoing Phase I study, we observed an interval of apparent disease stability during which the patient’s disease progression and requirement for platelet transfusion support did not increase following multiple infusions of CER-1236. While this is an early observation from a single patient and Phase I studies are primarily designed to evaluate safety, we believe the clinical course of this patient is noteworthy.  This patient had previously been diagnosed with myelodysplastic syndrome (MDS), a disorder of the bone marrow that can progress to acute myeloid leukemia (AML).

The emerging clinical observations provide an early signal that supports continued investigation of CER-1236. These data are helping guide the Company’s ongoing development strategy, including exploration of dosing approaches and patient selection in future cohorts.

While CER-1236 demonstrated activity across multiple tumor models during preclinical development, the observations to date in the MDS setting highlight a potentially important area for further study. We believe these early findings may also support future discussions with potential strategic partners regarding the continued development of the program.

Progress in Phase 1 Clinical Trial and Strategic Focus on MDS
We recently announced data from our ongoing CERTAIN-T Phase 1 clinical trial that reflects the Company’s current development approach for our lead compound, CER-1236. Based in part on early clinical observations in a patient with MDS, a disorder of the bone marrow that can precede AML, the Company has refined its development strategy to increase focus on enrolling patients with MDS while maintaining optionality in AML.

This strategic refinement was informed in part by observations from a patient who received four infusions of CER-1236 over approximately five months at the lowest dose level in the study.

As previously announced, prior to receiving CER-1236 the patient required frequent platelet transfusions. During the period following treatment in the study, the patient experienced an interval of platelet transfusion independence lasting more than two months, exceeding the commonly referenced ≥56-day durability benchmark used in MDS studies.

The Company is actively seeking to enroll additional patients with similar clinical characteristics to further evaluate this observation. If similar findings are observed in additional patients, these data may help inform future discussions with regulatory authorities and potential strategic partners regarding the continued development of CER-1236.

To date, the Company has initiated the second cohort of the trial, and two additional patients have recently undergone apheresis, a procedure in which blood cells are collected to manufacture CER-1236 for each individual patient. The Company plans to initiate dosing for these patients during March and April.

Pursuing a Strategy to List on a Major Exchange
Re-establishing our listing on a major exchange remains one of our key priorities.  To that end, we have engaged with an investment bank to raise capital and pursue a strategy intended to support a potential relisting on the Nasdaq Capital Market.  We believe that our new partner’s institutional relationships and sector expertise align well with our goal of raising sufficient capital in a disciplined manner while attracting longer-term, knowledgeable investors who are familiar with the clinical development landscape and strategic direction. In addition, we are considering other potential paths for relisting on a national securities exchange, including potential business combinations with listed companies, which may include a reverse merger or a business combination with a special purpose acquisition company.

Continued Funding Support
As recently disclosed, as we pursue new financing opportunities and seek to relist on Nasdaq, our lead investor continues to support CERo’s operations through investments in convertible debt. Their commitment to CERo has enabled us  to sustain operations and advance our clinical programs. We believe our clinical development and focus on our financing efforts and strategy for relisting on Nasdaq will be beneficial to all CERo stockholders and are grateful for the continued confidence our loyal stockholder base.

Strategic Discussions Regarding Early Data Readouts
We continue to engage in ongoing discussions with potential strategic partners following the most recent data readouts, as is regularly seen in the biotech industry. While these  conversations are encouraging, they remain at an early stage and have not resulted in formal agreements. We believe the evolution of our strategy and growing dataset may catalyze future conversations. To the extent permitted under applicable law and contractual obligations, we expect to provide further updates to stockholders should any of these discussions advance in a manner that materially impacts the Company.

Board Expansion – Appointment of Eric Francois
Finally, we recently announced that Eric Francois joined our board of directors.  Eric brings decades of experience in life sciences finance, capital markets, and corporate development, including deep expertise in capital raising, M&A, and strategic partnerships.  His involvement with the Company is among multiple catalysts that, we believe, will positively impact CERo in the months to come.  Eric was instrumental in our discussions with our new investment bank and is already assisting with other potential funding opportunities, operational improvements, and external viewpoints on the Company’s next phase of growth.

Dedicated, Engaged Professionals Working Together to Achieve Success
It should never go without saying that CERo’s world class team – employees, partners, consultants, and advisors – all remain focused and excited about achieving the common goal of improved patient care and improving patients’ lives through innovative clinical development.  Despite challenges that might have derailed other companies several times over, the CERo team has continued to perform with enthusiasm toward the achievement of bringing CER-1236 to the next inflection point and beyond.

Our take-home message is clear:  CERo is operational, continuing to advance our clinical programs, and generally building momentum. We are committed to transparent communication, and we look forward to sharing the outcomes of each of our ongoing activities in the future. We thank you for your continued support and confidence in our novel approach to treatment and our leadership.

Sincerely,
Chris Ehrlich
CEO
CERo Therapeutics

Company extends its consumer-first foundation beyond fitness equipment e-commerce into the design and deployment of AI-powered robotics and intelligent consumer technologies

Sydney, Australia, March 11, 2026 — In a move that redefines its corporate identity and market trajectory, Fitell Corporation (NASDAQ: FTEL) (“Fitell”, “GMEX Robotics” or the “Company”) today announces its rebranding to GMEX Robotics. The rebrand reflects a deliberate strategic evolution of the Company’s mission, extending its consumer-first foundation beyond fitness equipment e-commerce into the design and deployment of AI-powered robotics and intelligent consumer technologies.

“This rebrand is a revolution in our ambition, but an evolution of our expertise,” said Sam Lu, GMEX Robotics CEO. “As Fitell, we built a robust operation centered on consumer needs. As GMEX Robotics, we amplify that focus by applying advanced artificial intelligence and robotics to solve real human problems. Our fitness and health division remains a vital part of our operations; it is our testing ground and our inspiration. It ensures that as we build sophisticated robots, we never lose sight of the human they are designed to serve.”

The Company filed its amended and restated memorandum and articles of association in accordance with the BVI Business Companies Act (as amended) and, effective March 2, 2026, completed its legal name change to “GMEX ROBOTICS CORPORATION ” pursuant to such filing (the “Name Change“). In connection with the Name Change, the Company will also change its ticker symbol on the Nasdaq Capital Market (the “Nasdaq”) from “FTEL” to “GMEX” (the “Ticker Change“).

The Company’s Class A ordinary shares (“Ordinary Shares“) are expected to commence trading on the Nasdaq under the new corporate name and new ticker symbol as early as market open on March 12th, 2026. In connection with the name and ticker changes, the Company’s CUSIP number will remain unchanged. No action is required by existing shareholders, nor will any certificates representing Ordinary Shares need to be exchanged.

The rebrand reflects the next phase of the company’s long-term vision. Effective immediately, GMEX Robotics will focus on designing, manufacturing, and commercializing AI-driven robotic solutions for the consumer market, building on its foundation of expertise in fitness and health products. This shift represents the Company’s commitment to leading the next technological wave, where intelligent machines become an integral part of daily life. Rather than a wholesale departure from its roots, GMEX Robotics will continue to operate its existing fitness and health-related product business, which remains the crucial operational foundation for future growth. This legacy vertical functions as a hands-on laboratory for understanding human movement, ergonomics, and daily routines. The deep understanding of consumer wellness garnered through years of serving the fitness market will directly inform the design and development of the Company’s next generation robotic products.

GMEX Robotics will focus its efforts on three primary pillars:

1. Consumer and Commercial Robotics: Developing intuitive and interactive robots designed to assist with daily tasks, provide smart home integration, and offer new levels of convenience and connectivity to boost productivity.
2. AI-Driven Hardware: Embedding advanced artificial intelligence into physical products to create self-learning and adaptive user experiences.
3. Innovation & Ecosystem: Building a robust ecosystem of robotic products that communicate and evolve, powered by proprietary AI algorithms.

While the Company’s history in the fitness sector provides a strong foundation in logistics, supply chain management, and consumer engagement, GMEX Robotics is now engineered for a different market. The Company is actively assembling a new leadership team and technical workforce specializing in mechatronics, computer vision, and machine learning to drive this ambitious agenda.

The transition from Fitell to GMEX Robotics signifies the close of one chapter and the exciting, bold beginning of another. The Company invites investors, innovators, and consumers to join them as they build the intelligent future.

Today’s markets analysis on behalf of Zaheer Anwari – Co-Founder and CEO at The Revacy Fund

Oil prices remained volatile and moved higher today, although they continue to trade well below the peak reached earlier in the week. The market remains highly sensitive to developments in the Middle East, where elevated geopolitical tensions continue to expose energy infrastructure and shipping routes to significant risks.

Supply conditions have already tightened, as production in parts of the region has been curtailed due to limited storage capacity and difficulties in exporting crude amid shipping constraints. While some volumes have been redirected through pipelines, these alternatives could remain insufficient to fully offset the loss of maritime transport, leaving export capacity below normal levels.

At the same time, a coordinated release of strategic petroleum reserves by G7 countries could help ease immediate shortage concerns and stabilize prices. Additional measures, including insurance coverage for tankers and the use of military escorts, could support the resumption of shipments. If implemented effectively, these steps may limit further upside in oil and could lead to renewed downside pressure as supply fears begin to ease.

From a technical perspective, the reversal this week has brought oil prices back into a consolidation range, close to the levels observed for much of the period since 2023. Given the current conditions, caution remains prevalent regarding oil, while a clearer directional trend would typically be required before increasing allocation.

Unit 42 has identified and responsibly disclosed a high-severity vulnerability (CVE-2026-0628) affecting “Gemini Live in Chrome,” Google Chrome’s AI-powered side panel.

At a high level, the issue involved a privilege escalation or “privilege jump.” Chrome extensions typically operate within defined permission boundaries. However, Unit 42 found that a malicious extension could manipulate how the Gemini web app was loaded inside Chrome’s AI side panel — a browser environment that operates with higher privileges than a standard web tab.

Because the Gemini panel is treated as a trusted browser surface, influencing what loads inside it could allow an extension-controlled payload to execute in a more powerful context than the extension itself was granted.

How it worked: Privilege Escalation via AI Side Panels

The vulnerability allowed a malicious browser extension — even one with basic host permissions — to interfere with the Gemini Live side panel. Researchers found the extension could leverage Chrome’s request-modification capabilities to intercept and alter resources associated with the Gemini web application. This issue applied only when Gemini was accessed through the side panel, not a regular browser tab.

When loaded in the side panel, Gemini runs within a more privileged browser process, tightly integrated with browser features and granted enhanced capabilities that ordinary web pages do not have.

Due to how requests and content embedding were implemented, an extension permitted to interact with the Gemini domain could intercept and modify JavaScript resources before they were rendered in the panel. In effect, attacker-controlled code could be injected into content executing inside the panel’s higher-trust environment.

The extension itself did not gain new permissions. Instead, it manipulated the content pipeline feeding a privileged component. Because that component already had elevated capabilities, the injected code effectively “rode along” into a more powerful execution context — creating the privilege jump.

A successful exploit of CVE-2026-0628 could have enabled an attacker to:

• Access local files and directories
• Capture screenshots of browsing sessions
• Activate camera and microphone capabilities without appropriate awareness
• Execute phishing attacks within the trusted Gemini interface

The attack required no additional user interaction beyond installing a malicious extension and opening the Gemini panel.

Remediation and Protection

Palo Alto Networks notified Google on Oct. 23, 2025. Google confirmed the findings and released a fix in early January 2026.

Anupam Upadhyaya, SVP, Product Management, Prisma SASE, Palo Alto Networks, said, “Today’s agentic browsers can act on your behalf — researching, reasoning and taking action without direct user input. While this can deliver meaningful productivity gains, in the absence of enterprise-grade controls these tools can take autonomous actions beyond IT oversight. By inheriting a user’s browser session and accessing screens, files, cameras and microphones, agentic browsers can expand the attack surface through prompt manipulation and weakened web isolation, creating security and accountability gaps enterprises haven’t faced before.

The research highlights a broader architectural lesson: as AI becomes embedded into core browser components, strict isolation between extension-controlled content and privileged AI surfaces is essential to preserving the browser’s security model.

New Delhi, Mar 11: Servotech Renewable Power System Ltd., in collaboration with Electra EV, has been granted a patent by the Indian Patent Office for a pioneering Electric Vehicle Charging Device designed for low-voltage EVs. This innovation addresses a critical need in India’s rapidly growing electric mobility ecosystem by enabling safe, efficient, and reliable charging for sub-200V DC EV platforms. 

The patented technology resolves a key interoperability challenge, allowing low-voltage EVs – including vehicles based on GB/T Bharat DC 001 standards – to leverage conventional high-voltage CCS2 fast-charging infrastructure. This advancement is particularly relevant for small commercial EVs, pick-up vans, and other urban mobility solutions, where reliable low-voltage charging is essential for widespread adoption.

The device incorporates advanced power management and voltage conversion capabilities, ensuring safe energy transfer, optimal charging performance, and compatibility with widely deployed fast-charging systems. By improving charger interoperability and reliability, the technology supports the growth of India’s EV ecosystem, especially in last-mile and urban mobility segments.

Arun Handa, Chief Technology Officer, Servotech Renewable Power System Ltd., commented:

“Securing this patent is a significant milestone in our innovation-led approach to EV charging technology. Low-voltage electric vehicles are vital to India’s mobility ecosystem, particularly in small commercial fleets. This patented device ensures safe, efficient, and reliable charging, enabling faster EV adoption through improved charging compatibility.”

This joint patent between Servotech and Electra EV highlights both companies’ commitment to driving next-generation EV solutions and accelerating India’s transition to sustainable urban mobility.

CAPE TOWN, South Africa, Mar 11– Africa’s mineral-rich countries are moving quickly to unlock investment, diversify production and capture more value locally. Modernized mining codes and updated regulatory frameworks are giving investors clearer rules, more certainty and access to a wider range of critical minerals. By fostering transparency and strategic alignment, these reforms are not only attracting capital but also driving the development of downstream industries and positioning Africa as a key supplier for the global energy transition.

New Laws, New Deals

Liberia is preparing to introduce a new Mining Code within the next three months, creating a National Mining Company to increase state participation in major projects and strengthen its negotiating position. Nearly 80% of the country remains geologically unexplored, offering significant opportunities across minerals and even oil and gas.

“Liberia’s geology is exceptionally rich,” said Minister of Mines and Energy, Matenokay Tingban,  in an interview with Energy Capital & Power in January. “We are seeking geomapping and exploration partners. Access to geoscientific data will allow us to negotiate stronger investment deals and develop downstream infrastructure.”

Iron ore currently dominates the country’s output – targeting 30 million tons per year by 2026 – but the new framework is expected to encourage diversification into other critical resources while facilitating partnerships for exploration and downstream processing.

Meanwhile, Namibia is finalizing a new Minerals Bill to replace its 2002 legislation, reflecting the country’s commitment to local beneficiation, inclusive participation and investment competitiveness. According to Mining Commissioner at the Ministry of Industry and Mines, Isabella Chirchir, the reforms aim “to attract capital to diversify production beyond diamonds and uranium toward strategic metals such as lithium and rare earths.”

In Central Africa, the Republic of Congo approved a draft mining code in November 2025 introducing competitive bidding, formal permitting for small-scale miners and support for in-country processing. These measures aim to increase transparency, attract investors and strengthen the domestic value chain for both traditional and strategic minerals.

Reforms Fuel Opportunity

Across the continent, countries are updating existing codes to boost investment and production. Ivory Coast is revising its mining code to support a wider range of minerals, including chromium, coltan, lithium, copper, cobalt and iron ore, complementing its existing base of 19 operating mines. Somalia is also overhauling its mining regulations to unlock frontier resources such as uranium, lithium, cobalt, gold and diamonds, reflecting growing investor interest in previously underexplored markets.

The results of such reforms are already visible. Mali, which introduced a new Mining Code in 2023, continues as Africa’s second-largest gold producer while advancing lithium projects and a new gold refinery with international partners Barrick and B2Gold. Burkina Faso, which adopted a revised code in 2024, increased gold production from roughly 57–60 tons to 94 tons in 2025, reinforcing investor confidence and its position as Africa’s fourth-largest gold producer.

Against this backdrop, African Mining Week 2026 (October 14–16, Cape Town) will bring together policymakers, industry leaders and global investors to examine these regulatory transformations and the opportunities they unlock. From exploration to downstream processing, the event highlights how modernized frameworks are turning legal certainty into tangible investment potential, connecting capital with projects poised to drive Africa’s mining sector growth.

 

Bengaluru, Mar 11th: TechnoSport, India’s fastest-growing activewear brand, today announced the appointment of Achal Sharma as Chief Technology Officer (CTO), effective immediately. In this strategic role, Achal will lead the company’s technology vision and execution, driving innovation across digital platforms, data science, engineering, and product capabilities to support TechnoSport’s next phase of scale.

With over 18 years of experience building and scaling high-performance technology organisations, Achal brings deep expertise in platform engineering, DevOps, and enterprise-grade digital transformation. Over the course of his career, he has held senior technology leadership roles at leading consumer and digital-first companies including Wakefit, Myntra, Mobile Premier League, and Vision11. In these roles, he has successfully led large-scale engineering teams, architected resilient technology platforms, and institutionalised modern development practices that significantly enhanced product velocity, platform reliability, and system performance.

As Chief Technology Officer at TechnoSport, Achal will lead the company’s technology vision and play a pivotal role in accelerating its next phase of digital growth. He will focus on strengthening TechnoSport’s core technology architecture while driving a comprehensive digital transformation across channels and data-led decision frameworks.

Achal will oversee the evolution of both backend and customer-facing technology systems, with a strong emphasis on building scalable, resilient, and customer-centric digital experiences. In addition, he will shape and execute the company’s long-term technology roadmap in alignment with TechnoSport’s broader strategic ambitions.

Working closely with cross-functional leaders across product, marketing, supply chain, and operations, Achal will help architect integrated technology capabilities that power seamless omnichannel experiences, enhance operational agility, and enable data-driven decision-making across the organisation.

Puspen Maity, CEO, TechnoSport, said, “Achal’s leadership will be instrumental in delivering on our strategic priorities for the next phase of TechnoSport’s growth. His depth of experience in scaling tech teams and driving innovation aligns with our vision to harness technology as a core driver of customer value and operational excellence. We are confident Achal will play a pivotal role in strengthening our digital ecosystem.”

Achal Sharma, Chief Technology Officer, TechnoSport, said, “I’m excited to join TechnoSport at a time when technology is reshaping how lifestyle and performance brands engage with consumers. I look forward to working with the team to build platforms that are reliable, future-ready, and capable of supporting TechnoSport’s ambitions across India and beyond.”

Achal’s appointment underscores TechnoSport’s focus on building long-term technology leadership as the brand continues to scale its digital footprint and strengthen its presence in India’s activewear market.

San Francisco, CA – Mar. 11, 2026 – Contrivian, a technology company providing intelligent mission-critical connectivity, has signed an agreement as an authorized reseller with Amazon Leo to deliver resilient, high-performance connectivity for state and local agencies in the United States. The agreement expands Contrivian’s multi-modal connectivity solutions to deliver reliable networking that can support mission-critical applications and services.

Contrivian combines low Earth orbit technology with its proprietary Lighthouse performance optimization technology and NorthStar lifecycle management solution to deliver intelligent, software-defined multi-constellation connectivity. This eliminates the need for failover across networking technologies as well as across satellite constellations, with no disruption to applications or end users.

“We aren’t just providing satellite connectivity. We’re enabling mission-critical applications and services on a global scale. We’re providing software-enabled connectivity that is intelligently integrated, continuously monitored, and managed as part of a unified operational model,” said Grant Kirkwood, CEO of Contrivian. “Our agreement with Amazon Leo strengthens that architecture. It reflects how resilient networks must now be designed. It adds true diversity at the satellite layer and gives our customers greater control, greater performance stability, and greater assurance when failure is not an option.” 

Contrivian engineers, orchestrates, and manages mission-critical connectivity for organizations that operate in environments where downtime carries operational, financial, or safety risk. The company integrates fiber, broadband, LTE/5G, and low Earth orbit satellite into a single, performance-driven architecture. 

“Amazon Leo is developing the world’s most advanced satellite communication network. Through this agreement with Contrivian, we will provide essential connectivity to state and local government agencies, enabling them to stay connected and share vital information, even in isolated areas or during service disruptions,” said Carolyn Cuppernull, Business Development at Amazon Leo for Government. 

Contrivian serves public sector agencies, healthcare providers, energy operators, financial institutions, and other critical industries. It designs, deploys, monitors, and supports connectivity across fixed sites, remote facilities, and mobile operations worldwide. The company continues to invest in advanced satellite orchestration capabilities as the global low Earth orbit ecosystem evolves.